27 May 2016

Notice of Results

VERONA PHARMA PLC - Notice of Results

Read more

10 May 2016

Verona Pharma announces positive results from “add-on” Phase II trial with RPL554

Read more

4 May 2016

Verona to present RPL554 at the ATS Conference

VERONA PHARMA PLC - Verona to present RPL554 at the ATS Conference

Read more

4 May 2016

Verona to present clinical data on RPL554 at the ATS International Conference

Read more

19 April 2016

Change of Registered Office

VERONA PHARMA PLC - Change of Registered Office

Read more

15 April 2016

Holding(s) in Company

 

Read more

21 March 2016

Verona Pharma: 2015 in review

VERONA PHARMA PLC - Verona Pharma: 2015 in review

Read more

15 March 2016

Positive results from RPL554 dose-finding study

VERONA PHARMA PLC - Positive results from RPL554 dose-finding study

Read more

15 March 2016

Verona Pharma reports positive results from RPL554 dose-finding study

Read more

10 February 2016

Grant of Share Options

VERONA PHARMA PLC - Grant of Share Options

Read more

Innovative Therapies for Respiratory Care

See the 2017 Verona Pharma corporate video 2017

Runtime: 04:05

Go

The Lancet Respiratory Medicine

Peer-reviewed paper in the Lancet's highly-respected medication journal

Basic & Clinical Pharmacology & Toxicology

Peer-reviewed publication on dual PDE3/4 inhibitors as novel treatments for COPD

Close

Verona Pharma plc
3 More London Riverside, London SE1 2RE
T: +44 (0)203 283 4200

Linkedin     Email Us